Plain-English translation of NCT01252485 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a large registry study that gathers detailed information from patients with acute myeloid leukemia (a type of blood cancer) and related conditions. Researchers collect your medical history, treatment details, blood and bone marrow samples, and follow your progress over time. The goal is to better understand what makes each person's cancer unique and which treatments work best.
Acute myeloid leukemia is a serious blood cancer that affects each patient differently. By collecting information and samples from many patients, researchers can identify genetic markers and patterns that predict how someone will respond to treatment, ultimately leading to better, more personalized care for future patients.
You likely qualify if…
You likely don't qualify if…
You would visit one of the participating hospitals or cancer centers in Germany or Austria for your regular leukemia care. At these visits, researchers would collect your medical information, ask about your personal and family history, and take samples of your blood, bone marrow, and possibly other tissues. The study would follow your progress for up to 10 years, tracking how you respond to treatment and how you're doing overall.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Austria